References
- Araújo AAS, De Melo MGD, Rabelo TK, Nunes PS, Santos SL, Serafini MR, Santos MRV, Quintans-Junior LJ, Gelain DP. 2015. Review of the biological properties and toxicity of usnic acid. Nat Prod Res. 29(23):2167–2180.
- Bačkorová M, Bačkor M, Mikeš J, Jendželovský R, Fedoročko P. 2011. Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid. Toxicol in Vitro. 25(1):37–44.
- Berridge MV, Tan AS. 1993. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys. 303(2):474–482.
- Chollet-Krugler M, Tomasi S, Uriac P, Toupet L, Van De Weghe P. 2008. Preparation and characterization of copper(ii) and nickel(ii) complexes of a new chiral salen ligand derived from (+)-usnic acid. Dalton Trans. 46(46):6524–6526.
- Cirillo D, Borroni E, Festoso I, Monti D, Romeo S, Mazier D, Verotta L. 2018. Synthesis and antimycobacterial activity of (+)-usnic acid conjugates. Arch Pharm Chem Life Sci. 351(12):e1800177.
- Geng X, Zhang X, Zhou B, Zhang C, Tu J, Chen X, Wang J, Gao H, Qin G, Pan W. 2018. Usnic acid induces cycle arrest, apoptosis, and autophagy in gastric cancer cells In Vitro and In Vivo. Med Sci Monit. 24:556–566.
- Hansen PE, Mortensen J, Kamounah FS. 2015. The importance of correct tautomeric structures for biological molecules. JSM Chem. 3:1014–1018.
- Ingólfsdóttir K. 2002. Molecules of interest usnic acid. Phytochemistry. 61(7):729–736.
- Kutney JP, Sanchez IH. 1976. Studies in the usnic acid series. I. The condensation of (+)-usnic acid with aliphatic and aromatic amines. Can J Chem. 54(17):2795–2803.
- Luzina OA, Sokolov DN, Pokrovskii MA, Pokrovskii AG, Bekker OB, Danilenko VN, Salakhutdinov NF. 2015. Synthesis and biological activity of usnic acid enamine derivatives. Chem Nat Compd. 51(4):646–651.
- Nguyen HGT, Nguyen NV, Vo VA, Chun W, Kamounah FS, Vang O, Hansen PE. 2016. Synthesis, structure elucidation and cytotoxicity of (+)-usnic acid derivatives on U87MG glioblastoma gells. Nat Prod Chem Res. 4:1–6.
- Nguyen TT, Yoon S, Yang Y, Lee HB, Oh S, Jeong MH, Kim J-J, Yee ST, Crişan F, Moon C, et al. 2014. Lichen secondary metabolites in Flavocetraria cucullata exhibit anti-cancer effects on human cancer cells through the induction of apoptosis and suppression of tumorigenic potentials. PLoS One. 9(10):e111575.
- Nguyen VK, Sichaem J, Nguyen HH, Nguyen XH, Huynh TTL, Nguyen TP, Niamnont N, Mac DH, Pham DD, Chavasiri W, et al. 2019. Synthesis and cytotoxic evaluation of usnic acid benzylidene derivatives as potential anticancer agents. Nat Prod Res. :1–10. doi:10.1080/14786419.2019.1639176.
- Otto T, Sicinski P. 2017. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 17(2):93–115.
- Pyrczak-Felczykowska A, Narlawar R, Pawlik A, Guzow-Krzemińska B, Artymiuk D, Hać A, Ryś K, Rendina LM, Reekie TA, Herman-Antosiewicz A, et al. 2019. Synthesis of usnic acid derivatives and evaluation of their antiproliferative activity against cancer cells. J Nat Prod. 82(7):1768–1778.,
- Sherr CJ, Bartek J. 2017. Cell cycle–targeted cancer therapies. Annu Rev Cancer Biol. 1(1):41–57.
- Singh N, Nambiar D, Kale RK, Singh RP. 2013. Usnic acid inhibits growth and induces cell cycle arrest and apoptosis in human lung carcinoma A549 cells. Nutr Cancer. 65(sup1):36–43.
- Sperandio S, de Belle I, Bredesen DE. 2000. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA. 97(26):14376–14381.
- Takai M, Uehara Y, Beisler JA. 1979. Usnic acid derivatives as potential antineoplastic agents. J Med Chem. 22(11):1380–1384.
- Tomasi S, Picard S, Lainé C, Babonneau V, Goujeon A, Boustie J, Uriac P. 2006. Solid-phase synthesis of polyfunctionalized natural products: Application to usnic acid, a bioactive lichen compound. J Comb Chem. 8(1):11–14.
- Yang Y, Bae WK, Lee JY, Choi YJ, Lee KH, Park MS, Yu YH, Park SY, Zhou R, Taş İ, et al. 2018. Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. Sci Rep. 8(1):16234